01.12.2004 | Original Article
Two- vs three-drug combination chemotherapy in advanced or recurrent head and neck cancer
A single institution experience of 361 patients
Erschienen in: Medical Oncology | Ausgabe 4/2004
Einloggen, um Zugang zu erhalten